Richard Limbert, DO | |
2116 Megan Dr Ste 102, Cape Girardeau, MO 63701-1979 | |
(573) 335-7546 | |
(573) 335-7550 |
Full Name | Richard Limbert |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 13 Years |
Location | 2116 Megan Dr Ste 102, Cape Girardeau, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518222082 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | UO2949 (Florida) | Secondary |
207N00000X | Dermatology | 2015011824 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southeasthealth | Cape girardeau, MO | Hospital |
Saint Francis Medical Center | Cape girardeau, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Advanced Dermatology Of Southeast Missouri Pc | 3678612108 | 9 |
News Archive
Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.
A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored.
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
The New York Times explores how intra-GOP allegiances to the business community are changing. Meanwhile, AARP acknowleges that adjustments must be made, but argues against cutting back entitlements. Also in the news, the director of the National Institutes of Health expresses his wariness about the impact sequestration could have on biomedical research.
...a retrovirus found in macaques and other primates that so far has not been shown to cause disease in humans.
› Verified 7 days ago
Entity Name | Advanced Dermatology Of Southeast Missouri Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1770713950 PECOS PAC ID: 3678612108 Enrollment ID: O20091123000348 |
News Archive
Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.
A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored.
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
The New York Times explores how intra-GOP allegiances to the business community are changing. Meanwhile, AARP acknowleges that adjustments must be made, but argues against cutting back entitlements. Also in the news, the director of the National Institutes of Health expresses his wariness about the impact sequestration could have on biomedical research.
...a retrovirus found in macaques and other primates that so far has not been shown to cause disease in humans.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Richard Limbert, DO 2116 Megan Dr Ste 102, Cape Girardeau, MO 63701-1979 Ph: (573) 335-7546 | Richard Limbert, DO 2116 Megan Dr Ste 102, Cape Girardeau, MO 63701-1979 Ph: (573) 335-7546 |
News Archive
Pharmalink AB, a privately held Swedish pharmaceutical company, has received orphan drug designation by the US Food and Drug Administration (FDA) for its product candidate Nefecon (PL-56) for patients with IgA nephropathy, also referred to as Berger's Disease. This program is presently in clinical development phase II.
A new study will be examining the implications of when and how NHS healthcare professionals re-contact patients with new genetic information that may impact their health or that of their family. The three year Economic and Social Research Council funded research will also explore issues of consent and how genetic information is stored.
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
The New York Times explores how intra-GOP allegiances to the business community are changing. Meanwhile, AARP acknowleges that adjustments must be made, but argues against cutting back entitlements. Also in the news, the director of the National Institutes of Health expresses his wariness about the impact sequestration could have on biomedical research.
...a retrovirus found in macaques and other primates that so far has not been shown to cause disease in humans.
› Verified 7 days ago
Dr. Charles M. Moon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1359 N Mount Auburn Rd, Cape Girardeau, MO 63701 Phone: 573-335-7546 Fax: 573-335-7550 | |
Dr. Lawrence Feigenbaum, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 304 S Mount Auburn Rd, Cape Girardeau, MO 63703 Phone: 573-803-3331 |